三鑫医疗 (300453.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

11.0x

Market Cap

CNY 5.08B

MomentumView details →

1D Return

−1.72%

YTD Return

+5.16%

RSI (14)

38.9

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

11.0x

Market Cap

CNY 5.08B

RSI (14)

38.9

MomentumView details →

1D Return

−1.72%

YTD Return

+5.16%

ProfitabilityView details →

Gross Margin

36.59%

Net Margin

16.56%

EBITDA Margin

26.46%

ROE (TTM)

18.29%

ROA (TTM)

11.44%

Asset Turnover

0.69x

GrowthView details →

Revenue YoY

+10.37%

EPS YoY

+22.99%

FCF YoY

−1.68%

Revenue CAGR 3Y

+7.08%

EPS CAGR 3Y

+12.59%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.14x

Current Ratio

1.63x

Quick Ratio

1.20x

Div Yield

3.27%

Div Rate

CNY 0.30

Div Growth 1Y

−33.33%

Financials snapshotView financials →

Revenue (TTM)

1.69B

Net Income (TTM)

279.57M

Op. CF (TTM)

416.53M

Latest newsMore news →

Sanxin Medical signed tripartite and quadripartite supervision agreements with banks and sponsor Guosen Securities to monitor the use of raised funds.3d ago

Sanxin Medical announced a cash dividend of 1 yuan per 10 shares based on 522 million shares.12d ago

Similar companies

*ST威领002667.SZ 小熊电器002959.SZ 海达股份300320.SZ 罗欣药业002793.SZ 陇神戎发300534.SZ 溯联股份301397.SZ Find similar companies →

Latest newsMore news →

Sanxin Medical signed tripartite and quadripartite supervision agreements with banks and sponsor Guosen Securities to monitor the use of raised funds.3d ago Sanxin Medical announced a cash dividend of 1 yuan per 10 shares based on 522 million shares.12d ago Sanxin Medical announced its 2026 first-half results with net profit of 132 million yuan, up 14.77% year-on-year.12d ago